
General SurgeryCost-Effectivenessquality-adjusted life years
Cost-effectiveness of Robotic Versus Open Pancreatoduodenectomy: Insights from the DIPLOMA-2 Multicenter Randomized Trial
By MedXY|Aug 17, 2026
This randomized trial analysis compares the costs and quality-adjusted life years of robotic versus open pancreatoduodenectomy, revealing no significant cost differences but a lower probability that robotic surgery is cost-effective at six